Wealth Effects LLC Has $273,000 Stock Holdings in Dolby Laboratories, Inc. (NYSE:DLB)

Wealth Effects LLC trimmed its holdings in shares of Dolby Laboratories, Inc. (NYSE:DLB) by 44.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,500 shares of the electronics maker’s stock after selling 2,800 shares during the quarter. Wealth Effects LLC’s holdings in Dolby Laboratories were worth $273,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in DLB. Boston Trust Walden Corp increased its holdings in Dolby Laboratories by 185.3% during the 3rd quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock worth $82,276,000 after purchasing an additional 698,283 shares in the last quarter. Clifford Capital Partners LLC boosted its position in Dolby Laboratories by 3,114.7% during the 3rd quarter. Clifford Capital Partners LLC now owns 270,579 shares of the electronics maker’s stock worth $20,707,000 after acquiring an additional 262,162 shares during the last quarter. Thrivent Financial for Lutherans grew its stake in shares of Dolby Laboratories by 496.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 102,223 shares of the electronics maker’s stock worth $7,823,000 after acquiring an additional 85,093 shares in the last quarter. Marshall Wace LLP acquired a new stake in shares of Dolby Laboratories in the second quarter valued at approximately $6,131,000. Finally, Disciplined Growth Investors Inc. MN lifted its position in shares of Dolby Laboratories by 4.5% in the third quarter. Disciplined Growth Investors Inc. MN now owns 1,466,212 shares of the electronics maker’s stock worth $112,209,000 after purchasing an additional 63,589 shares in the last quarter. Institutional investors own 58.56% of the company’s stock.

Insider Activity at Dolby Laboratories

In other Dolby Laboratories news, SVP John D. Couling sold 7,000 shares of Dolby Laboratories stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $80.50, for a total value of $563,500.00. Following the completion of the sale, the senior vice president now owns 106,806 shares in the company, valued at $8,597,883. The trade was a 6.15 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Ryan Nicholson sold 10,500 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $80.18, for a total transaction of $841,890.00. Following the transaction, the chief accounting officer now directly owns 24,364 shares in the company, valued at $1,953,505.52. This represents a 30.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 135,917 shares of company stock worth $10,877,739. Company insiders own 38.39% of the company’s stock.

Dolby Laboratories Stock Performance

Shares of NYSE:DLB opened at $81.15 on Tuesday. The company has a 50-day simple moving average of $78.98 and a 200 day simple moving average of $75.61. The company has a market capitalization of $7.75 billion, a P/E ratio of 29.95 and a beta of 0.98. Dolby Laboratories, Inc. has a 52-week low of $66.35 and a 52-week high of $85.30.

Dolby Laboratories Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were issued a dividend of $0.33 per share. The ex-dividend date was Tuesday, December 3rd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 dividend on an annualized basis and a dividend yield of 1.63%. Dolby Laboratories’s payout ratio is presently 48.71%.

Analyst Ratings Changes

DLB has been the subject of a number of analyst reports. Barrington Research reaffirmed an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Monday. StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 4th. Finally, Rosenblatt Securities reissued a “buy” rating and set a $100.00 price target on shares of Dolby Laboratories in a research report on Thursday, January 23rd.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.